Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhotoDynamic is a Canadian biotechnology company that develops light-activated antimicrobial treatments based on photodynamic therapy (PDT). The company utilizes a proprietary, plant-derived photosensitizer that is activated by a specialized light-emitting device to selectively destroy pathogenic bacteria. Their flagship product is designed for oral health, providing a fast and effective method to eliminate dental plaque and manage gingivitis. PhotoDynamic's technology platform aims to provide a non-invasive alternative to traditional antibiotics, reducing the risk of antimicrobial resistance in various clinical applications. Beyond dentistry, the company is exploring applications for its platform in wound care and other infectious disease settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhotoDynamic.